Syringomyelia is a spinal cord disease characterized by fluid-filled cavities within the spinal cord tissue, which was first described over 400 years ago. However, the mechanism by which these cavities are formed is still not fully understood. In 1980, neurosurgeon Bernard Williams hypothesized that pressure changes due to coughing, sneezing, and straining, caused fluid in the cavity to “slosh” thus generating stress in the spinal cord tissue, and allowing the cavity to slowly expand over time.

Syringomyelia is common in brachycephalic (flat-faced) toy breed dogs. In humans, the disease can be painful and disabling, often seen alongside Chiari malformation, a condition where the lower part of the brain pushes down and extends into the spinal canal. In some cases, the malformation can be a direct result of serious spinal cord trauma.

Dr. Srdjan Cirovic, Lecturer in Biomedical Engineering, and Professor Clare Rusbridge, Professor in Veterinary Neurology have worked together to develop a supercomputer model based on the MRI from a Cavalier King Charles spaniel with syringomyelia, showing that Bernard Williams hypothesis from 1980 is likely correct.  

By using this model, the pair used various simulations to show that the fluid “slosh” caused a small cavity to gradually expand down the spinal cord. However, when the syrinx became large, there was less focal stress which may explain why syringomyelia can develop rapidly but then remain unchanged in shape over time.

Dr. Srdjan Cirovic and Professor Clare Rusbridge plan to further develop the model to improve understanding of why syringomyelia develops in both dogs and humans, and also use it as an opportunity to model potential surgeries to better establish means of reversing the syrinx filling in all species.

Clare Rusbridge, Professor in Veterinary Neurology at the University of Surrey said: “The results for the simulations of an expanding syrinx are broadly consistent with the homeostatic hypothesis, however, this study specifically addresses syringomyelia in dogs; more specifically in a Cavalier King Charles Spaniel. Since there are many similarities in syringomyelia in both humans and animals, it is likely the theory should hold for humans too. However, more analysis needs to be done to understand this in further detail.”

Dr. Srdjan Cirovic, Lecturer in Biomedical Engineering at the University of Surrey, said: “It has been both fascinating and challenging to work on the problem of syringomyelia over the last decade. With this breakthrough, we are one step closer to understanding this puzzling neurological condition. In the future, we are looking towards using these findings to inform the improved medical treatment of syringomyelia in humans as well as animals.”

Dr. Helen Williams, General Practitioner and daughter of Bernard Williams said: “This is a significant and important piece of work, and thanks to the hard work of two researchers, I am delighted to hear that my late father’s 40-year-old hypothesis is now much closer to being proven. This is key to further understanding more about this debilitating disease and how it can be treated.”

Genes aren’t only inherited through birth. Bacteria can pass genes to each other, or pick them up from their environment, through a process called horizonal gene transfer, which is a major culprit in the spread of antibiotic resistance.

Cornell researchers used machine learning to sort organisms by their functions and use this information to predict with near-perfect accuracy how genes are transferred between them, an approach that could potentially be used to stop the spread of antibiotic resistance.

The team’s paper, “Functions Predict Horizontal Gene Transfer and the Emergence of Antibiotic Resistance,” published Oct. 22 in Science Advances. The lead author is doctoral student Hao Zhou.

“Organisms basically can acquire resistance genes from other organisms. And so it would help if we knew which organisms bacteria were exchanging with, and not only that, but we could figure out what are the driving factors that implicate organisms in this transfer,” said Ilana Brito, assistant professor and the Mong Family Sesquicentennial Faculty Fellow in Biomedical Engineering in the College of Engineering, and the paper’s senior author. “If we can figure out who is exchanging genes with who, then maybe it would give insight into how this actually happens and possibly even control these processes.”

Many novel traits are shared through gene transfer. But scientists haven’t been able to determine why some bacteria engage in gene transfer while others do not.

Instead of testing individual hypotheses, Brito’s team looked to bacteria genomes and their various functions – which can range from DNA replication to metabolizing carbohydrates – in order to identify signatures that indicate “who” were swapping genes and what was driving these networks of exchange.

Brito’s team used several machine-learning models, each of which teased out different phenomena embedded in the data. This enabled them to identify multiple networks of different antibiotic resistance genes, and across strains of the same organism.

For the study, the researchers focused on organisms associated with soil, plants and oceans, but their model is also well-suited to look at human-associated organisms and pathogens, such as Acinetobacter baumannii and E. coli, and within localized environments, such as an individual’s gut microbiome.

They found the machine-learning models were particularly effective when applied to antibiotic resistance genes.

“I think one of the big takeaways here is that the network of bacterial gene exchange – specifically for antibiotic resistance – is predictable,” Brito said. “We can understand it by looking at the data, and we can do better if we actually look at each organism's genome. It’s not a random process.”

One of the most surprising findings was that the modeling predicted many possible antibiotic resistance transfers between human-associated bacteria and pathogens that haven’t yet been observed. These probable, yet undetected, transfer events were almost exclusive to human-associated bacteria in the gut microbiome or oral microbiome.

The research is emblematic of Cornell’s recently launched Center for Antimicrobial Resistance, according Brito, who serves on the center’s steering committee.

“One can imagine that if we can predict how these genes spread, we might be able to either intervene or choose a specific antibiotic, depending what we see in a patient’s gut,” Brito said. “More broadly, we may see where certain types of organisms are predicted to transfer with others in a certain environment. And we think there might be novel antibiotic targets in the data. For example, genes that could cripple these organisms, potentially, in terms of their ability to persist in certain environments or acquire these genes.”